Hamilton Lane (NASDAQ:HLNE) Price Target Increased to $185.00 by Analysts at UBS Group

Hamilton Lane (NASDAQ:HLNEGet Free Report) had its target price increased by research analysts at UBS Group from $150.00 to $185.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price objective points to a potential upside of 4.20% from the company’s previous close.

Other analysts have also recently issued research reports about the company. Morgan Stanley lifted their price objective on Hamilton Lane from $140.00 to $182.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. The Goldman Sachs Group boosted their price objective on shares of Hamilton Lane from $139.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. Keefe, Bruyette & Woods upped their price objective on shares of Hamilton Lane from $135.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, August 7th. Wells Fargo & Company lifted their target price on shares of Hamilton Lane from $156.00 to $170.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 9th. Finally, JPMorgan Chase & Co. increased their price target on Hamilton Lane from $120.00 to $134.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. Seven analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $160.50.

Check Out Our Latest Report on Hamilton Lane

Hamilton Lane Price Performance

Shares of NASDAQ HLNE traded down $1.59 on Tuesday, hitting $177.54. The company’s stock had a trading volume of 9,260 shares, compared to its average volume of 311,698. The stock has a 50 day moving average of $159.30 and a 200-day moving average of $136.11. The company has a market capitalization of $9.59 billion, a price-to-earnings ratio of 48.11 and a beta of 1.19. Hamilton Lane has a 12-month low of $78.66 and a 12-month high of $181.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.72 and a quick ratio of 2.72.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $1.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.41. The firm had revenue of $196.73 million for the quarter, compared to analyst estimates of $149.84 million. Hamilton Lane had a return on equity of 34.36% and a net margin of 26.99%. During the same quarter in the prior year, the company earned $0.94 EPS. As a group, research analysts predict that Hamilton Lane will post 4.88 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in HLNE. Vanguard Group Inc. lifted its stake in shares of Hamilton Lane by 8.3% in the 1st quarter. Vanguard Group Inc. now owns 3,678,617 shares of the company’s stock valued at $414,801,000 after purchasing an additional 283,190 shares in the last quarter. Geneva Capital Management LLC acquired a new position in Hamilton Lane during the first quarter valued at approximately $22,395,000. American Century Companies Inc. grew its stake in Hamilton Lane by 30.3% during the second quarter. American Century Companies Inc. now owns 580,768 shares of the company’s stock worth $71,772,000 after buying an additional 135,040 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Hamilton Lane in the first quarter worth $11,445,000. Finally, Capital World Investors purchased a new position in shares of Hamilton Lane in the 1st quarter valued at $9,724,000. 97.40% of the stock is owned by hedge funds and other institutional investors.

Hamilton Lane Company Profile

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Featured Stories

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.